This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
PALMER: improving pathway annotation based on the biomedical literature mining with a constrained latent block model
BMC Bioinformatics Open Access 02 October 2020
-
ERBB2/HER2 mutations are transforming and therapeutically targetable in leukemia
Leukemia Open Access 04 May 2020
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Broughton SE, Nero TL, Dhagat U, Kan WL, Hercus TR, Tvorogov D et al. The betac receptor family - Structural insights and their functional implications. Cytokine 2015; 74: 247–258.
Hercus TR, Dhagat U, Kan WL, Broughton SE, Nero TL, Perugini M et al. Signalling by the betac family of cytokines. Cytokine Growth Factor Rev 2013; 24: 189–201.
D'Andrea R, Rayner J, Moretti P, Lopez A, Goodall GJ, Gonda TJ et al. A mutation of the common receptor subunit for interleukin-3 (IL-3), granulocyte-macrophage colony-stimulating factor, and IL-5 that leads to ligand independence and tumorigenicity. Blood 1994; 83: 2802–2808.
Hannemann J, Hara T, Kawai M, Miyajima A, Ostertag W, Stocking C . Sequential mutations in the interleukin-3 (IL3)/granulocyte-macrophage colony-stimulating factor/IL5 receptor beta-subunit genes are necessary for the complete conversion to growth autonomy mediated by a truncated beta C subunit. Mol Cell Biol 1995; 15: 2402–2412.
Jenkins BJ, Blake TJ, Gonda TJ . Saturation mutagenesis of the beta subunit of the human granulocyte-macrophage colony-stimulating factor receptor shows clustering of constitutive mutations, activation of ERK MAP kinase and STAT pathways, and differential beta subunit tyrosine phosphorylation. Blood 1998; 92: 1989–2002.
Tanaka T, Motoi N, Tsuchihashi Y, Tazawa R, Kaneko C, Nei T et al. Adult-onset hereditary pulmonary alveolar proteinosis caused by a single-base deletion in CSF2RB. J Med Genet 2011; 48: 205–209.
Maxson JE, Gotlib J, Pollyea DA, Fleischman AG, Agarwal A, Eide CA et al. Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML. N Engl J Med 2013; 368: 1781–1790.
Forbes SA, Beare D, Gunasekaran P, Leung K, Bindal N, Boutselakis H et al. COSMIC: exploring the world's knowledge of somatic mutations in human cancer. Nucleic Acids Res 2015; 43 (Database issue): D805–D811.
The Genomes Project C, Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM et al A global reference for human genetic variation. Nature 2015; 526: 68–74.
Lek M, Karczewski K, Minikel E, Samocha K, Banks E, Fennell T et al. Analysis of protein-coding genetic variation in 60,706 humans. BioRxiv 2015; doi:10.1101/030338.
Zhang J, Walsh MF, Wu G, Edmonson MN, Gruber TA, Easton J et al. Germline mutations in predisposition genes in pediatric cancer. N Engl J Med 2015; 373: 2336–2346.
Dong F, Brynes RK, Tidow N, Welte K, Lowenberg B, Touw IP . Mutations in the gene for the granulocyte colony-stimulating-factor receptor in patients with acute myeloid leukemia preceded by severe congenital neutropenia. N Engl J Med 1995; 333: 487–493.
McMahon DP, Lance A, Price AE, Gerber JM, Baxter SA, Druhan LJ et al. Congenital neutrophilia arising from a T618I germline mutation in the CSF3R gene. Blood 2015; 126: 1623.
Sokol L, Luhovy M, Guan Y, Prchal JF, Semenza GL, Prchal JT . Primary familial polycythemia: a frameshift mutation in the erythropoietin receptor gene and increased sensitivity of erythroid progenitors to erythropoietin. Blood 1995; 86: 15–22.
Ding J, Komatsu H, Wakita A, Kato-Uranishi M, Ito M, Satoh A et al. Familial essential thrombocythemia associated with a dominant-positive activating mutation of the c-MPL gene, which encodes for the receptor for thrombopoietin. Blood 2004; 103: 4198–4200.
Zenatti PP, Ribeiro D, Li W, Zuurbier L, Silva MC, Paganin M et al. Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia. Nat Genet 2011; 43: 932–939.
Kjaer S, Kurokawa K, Perrinjaquet M, Abrescia C, Ibanez CF . Self-association of the transmembrane domain of RET underlies oncogenic activation by MEN2A mutations. Oncogene 2006; 25: 7086–7095.
Tyner JW, Yang WF, Bankhead A 3rd, Fan G, Fletcher LB, Bryant J et al. Kinase pathway dependence in primary human leukemias determined by rapid inhibitor screening. Cancer Res 2013; 73: 285–296.
Rawlings JS, Rosler KM, Harrison DA . The JAK/STAT signaling pathway. J Cell Sci 2004; 117 (Pt 8): 1281–1283.
Acknowledgements
We thank Dr Caroline Enns and Dr William Skach, for guidance on the non-reducing PAGE experiments. We also thank David K. Edwards V (NSF GRFP DGE-1448072) and Marilynn Chow (Knight Cancer Institute) for critical review of the manuscript. This work was funded by a Howard Hughes Medical Institute Investigator award and NIH/NCI MERIT award (R37CA065823) to BJD, and NIH/NCI R00 award (5R00CA151670-04) to AA. KWS was supported by a T32 program training grant (5T32GM071338-08), Knight Cancer Institute stipend award and the Allan Price memorial ARCS scholar award. BJD and JT are also supported by Leukemia Lymphoma Society (LLS) Beat AML program. JPPM was supported by KiKa foundation grants (2010-082, 2013-123) and the Dutch Cancer society (EMCR-KWF-20110-4691).
Author contributions
KWS designed and performed research, interpreted the data and wrote the manuscript. CT and AA designed the research and edited the manuscript. JPPM supplied essential samples, provided critical feedback and reviewed the manuscript. BJD and JWT provided critical feedback and reviewed the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
JWT receives research support from Incyte. The remaining authors declare no conflict of interest.
Additional information
Supplementary Information accompanies this paper on the Leukemia website
Supplementary information
Rights and permissions
About this article
Cite this article
Watanabe-Smith, K., Tognon, C., Tyner, J. et al. Discovery and functional characterization of a germline, CSF2RB-activating mutation in leukemia. Leukemia 30, 1950–1953 (2016). https://doi.org/10.1038/leu.2016.95
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2016.95